Showing results (21-30 of 172) with videos related to
Sort By:
Pageof 18
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 28, 2017
Circadian variations in the pharmacokinetics of capecitabine and its metabolites in ratsShinji Kobuchi, Yukiko Yazaki, Yukako Ito, et al.Journal of Pharmaceutical Sciences|April 21, 2020
Population Pharmacokinetic Model-Based Evaluation of Circadian Variations in Plasma 5-Fluorouracil Concentrations During Long-Term Infusion in Rats: A Comparison With Oral Anticancer ProdrugsShinji Kobuchi, Eisuke Matsumura, Yukako Ito, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 28, 2015
Population pharmacokinetic modelling and simulation of 5-fluorouracil incorporating a circadian rhythm in ratsShinji Kobuchi, Yukako Ito, Yuya Nakano, et al.International Journal of Medical Sciences|June 25, 2013
Data mining of the public version of the FDA Adverse Event Reporting SystemToshiyuki Sakaeda, Akiko Tamon, Kaori Kadoyama, et al.International Journal of Medical Sciences|April 2, 2014
Commonality of drug-associated adverse events detected by 4 commonly used data mining algorithmsToshiyuki Sakaeda, Kaori Kadoyama, Keiko Minami, et al.Biological & Pharmaceutical Bulletin|June 13, 2012
Adverse event profile of tigecycline: data mining of the public version of the U.S. Food and Drug Administration adverse event reporting systemKaori Kadoyama, Toshiyuki Sakaeda, Akiko Tamon, et al.Organic Letters|May 1, 2009
Hydroxyl group-directed organocatalytic asymmetric Michael addition of alpha,beta-unsaturated ketones with alkenylboronic acidsTsubasa Inokuma, Kiyosei Takasu, Toshiyuki Sakaeda, et al.Advanced Drug Delivery Reviews|January 13, 2009
Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapyToshiyuki Sakaeda, Motohiro Yamamori, Akiko Kuwahara, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 26, 2015
A quantitative LC-MS/MS method for determining ipragliflozin, a sodium-glucose co-transporter 2 (SGLT-2) inhibitor, and its application to a pharmacokinetic study in ratsShinji Kobuchi, Yukako Ito, Kyoka Yano, et al.Cancer Chemotherapy and Pharmacology|April 3, 2020
Assessment of pharmacokinetic variations of capecitabine after multiple administration in rats: a physiologically based pharmacokinetic modelShuhei Sakai, Shinji Kobuchi, Yukako Ito, et al.Pageof 18